- Home
- FBYD vs SCPH Comparison
FBYD vs SCPH Comparison
Compare FBYD & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBYD
- SCPH
- Stock Information
- Founded
- FBYD 2021
- SCPH 2013
- Country
- FBYD United States
- SCPH United States
- Employees
- FBYD N/A
- SCPH N/A
- Industry
- FBYD
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- FBYD
- SCPH Health Care
- Exchange
- FBYD Nasdaq
- SCPH Nasdaq
- Market Cap
- FBYD 152.9M
- SCPH 173.6M
- IPO Year
- FBYD N/A
- SCPH 2017
- Fundamental
- Price
- FBYD $7.08
- SCPH $3.25
- Analyst Decision
- FBYD
- SCPH Strong Buy
- Analyst Count
- FBYD 0
- SCPH 2
- Target Price
- FBYD N/A
- SCPH $15.00
- AVG Volume (30 Days)
- FBYD 48.7K
- SCPH 261.4K
- Earning Date
- FBYD 02-28-2025
- SCPH 03-12-2025
- Dividend Yield
- FBYD N/A
- SCPH N/A
- EPS Growth
- FBYD N/A
- SCPH N/A
- EPS
- FBYD N/A
- SCPH N/A
- Revenue
- FBYD $7,530,000.00
- SCPH $30,278,000.00
- Revenue This Year
- FBYD N/A
- SCPH $172.27
- Revenue Next Year
- FBYD N/A
- SCPH $131.75
- P/E Ratio
- FBYD N/A
- SCPH N/A
- Revenue Growth
- FBYD N/A
- SCPH 303.87
- 52 Week Low
- FBYD $3.62
- SCPH $3.08
- 52 Week High
- FBYD $13.25
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- FBYD 56.09
- SCPH 43.27
- Support Level
- FBYD $6.62
- SCPH $3.09
- Resistance Level
- FBYD $7.87
- SCPH $3.87
- Average True Range (ATR)
- FBYD 1.23
- SCPH 0.20
- MACD
- FBYD 0.22
- SCPH 0.00
- Stochastic Oscillator
- FBYD 54.90
- SCPH 20.65
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.